NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/27/2024
Back to search
Official data from USPTO
IMMUNEED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
02/27/2024
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
07/13/2022
Registration date
02/27/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/27/2024
Last transaction
02/27/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/09/2022
First use in commerce
06/09/2022
Drawing code
4
Owner type
03
Owner location
Uppsala, SE
Examiner
CORNWELL, ANDREA
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Immuneed AB
Representatives
Donna J. Bunton NIXON & VANDERHYE P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Testing, biochemical analysis, characterization in the nature of testing to determine pharmaceutical benefits, research and development of pharmaceutical products and vaccine products for others; pharmaceutical research and development; medical and pharmacological research services; testing and analysis of immunotherapy services to assure compliance with industry standards; research and development of immunotherapy treatment methods; biochemical research; immunotherapeutic research; scientific genetics research; immunotherapeutic research in the field of drug safety and immunology; pharmaceutical drug development services; research relating to medicines; drug discovery services; laboratory research in the field of medicine, immunotherapy and cancer
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/26/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/26/2023
ALIE
ASSIGNED TO LIE
10/26/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/26/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/18/2023
GNFR
FINAL REFUSAL E-MAILED
05/18/2023
CNFR
FINAL REFUSAL WRITTEN
05/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/16/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/02/2023
GNRT
NON-FINAL ACTION E-MAILED
05/02/2023
CNRT
NON-FINAL ACTION WRITTEN
05/02/2023
DOCK
ASSIGNED TO EXAMINER
04/27/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/02/2022
NWAP
NEW APPLICATION ENTERED
07/16/2022
Continuous trademark protection
Get notified about every new filing that threatens IMMUNEED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.